Adriamycin (ADM) induced apoptosis in transitional cell cancer (TCC) cell lines accompanied by p21(WAF1/CIP1) induction

被引:12
作者
Bilim, VN
Tomita, Y
Kawasaki, T
Takeda, M
Takahashi, K
机构
[1] Department of Urology, Niigata University, School of Medicine, Niigata 951
关键词
adriamycin (ADM); apoptosis; Bax; Bcl-2; p21(WAF1/CIP1); p53; transitional cell cancer (TCC); WILD-TYPE P53; DNA DAMAGE; DRUG-RESISTANCE; URINARY-TRACT; IRON COMPLEX; BCL-2; GENE; IN-VIVO; EXPRESSION; PROTEIN; DEATH;
D O I
10.1023/A:1026472700554
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genotoxic stimuli, including anticancer drugs, induce apoptosis in cancer cells through increase of p53, p21(WAF1/CIP1), at least in part. Bcl-2 and Bax modify this pathway or directly regulated by p53. Here we studied Adriamycin (ADM)-induced apoptosis in four human bladder cancer cell lines-in respect of p53, p21(WAF1/CIP1) and Bcl-2 family proteins. After ADM, treatment bladder cancer cells underwent dose-dependent cell death with typical morphologic features of apoptosis. Among four cell lines RT4 with wt p53, low ratio of Bcl-2 to Bax and induction of p21(WAF1/CIP1) after ADM treatment, was the most sensitive to induction of apoptosis. Thus, p53, p21(WAF1/CIP1), Bcl-2 and Bax status might determine susceptibility of bladder cancer cells to ADM induced apoptosis.
引用
收藏
页码:207 / 213
页数:7
相关论文
共 40 条
[1]  
BIEDLER JL, 1994, CANCER RES, V54, P666
[2]   Prognostic value of Bcl-2 and p53 expression in urinary tract transitional cell cancer [J].
Bilim, V ;
Tomita, Y ;
Kawasaki, T ;
Katagiri, A ;
Imai, T ;
Takeda, M ;
Takahashi, K .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (10) :686-688
[3]   GENERAL METHOD FOR ISOLATION OF HIGH MOLECULAR-WEIGHT DNA FROM EUKARYOTES [J].
BLIN, N ;
STAFFORD, DW .
NUCLEIC ACIDS RESEARCH, 1976, 3 (09) :2303-2308
[4]   BCL-X, A BCL-2-RELATED GENE THAT FUNCTIONS AS A DOMINANT REGULATOR OF APOPTOTIC CELL-DEATH [J].
BOISE, LH ;
GONZALEZGARCIA, M ;
POSTEMA, CE ;
DING, LY ;
LINDSTEN, T ;
TURKA, LA ;
MAO, XH ;
NUNEZ, G ;
THOMPSON, CB .
CELL, 1993, 74 (04) :597-608
[5]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221
[6]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]   OXIDATIVE DESTRUCTION OF DNA BY THE ADRIAMYCIN IRON COMPLEX [J].
ELIOT, H ;
GIANNI, L ;
MYERS, C .
BIOCHEMISTRY, 1984, 23 (05) :928-936
[9]  
HARPER JW, 1993, CELL, V75, P805
[10]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53